Evidence map›Paper›PMID 35948836›Full record

ArticleWorld journal of microbiology & biotechnology2022

iChip increases the success of cultivation of TBT-resistant and TBT-degrading bacteria from estuarine sediment.

A Polrot, J R Kirby, F J Olorunniji, J W Birkett, G P Sharples

Open access · hybridAbstract read
In one paragraph

Article in World journal of microbiology & biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

A PolrotLiverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.ORCID http://orcid.org/0000-0002-8032-4827
J R KirbyLiverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK. J.R.Kirby@ljmu.ac.uk.
F J OlorunnijiLiverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.
J W BirkettLiverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.
G P SharplesLiverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.
Liverpool John Moores University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Standard methods of microbial cultivation only enable the isolation of a fraction of the total environmental bacteria. Numerous techniques have been developed to increase the success of isolation and cultivation in the laboratory, some of which derive from diffusion chambers. In a diffusion chamber, environmental bacteria in agar medium are put back in the environment to grow as close to their natural conditions as possible, only separated from the environment by semi-permeable membranes. In this study, the iChip, a device that possesses hundreds of mini diffusion chambers, was used to isolate tributyltin (TBT) resistant and degrading bacteria. IChip was shown to be efficient at increasing the number of cultivable bacteria compared to standard methods. TBT-resistant strains belonging to Oceanisphaera sp., Pseudomonas sp., Bacillus sp. and Shewanella sp. were identified from Liverpool Dock sediment. Among the isolates in the present study, only members of Pseudomonas sp. were able to use TBT as a sole carbon source. It is the first time that members of the genus Oceanisphaera have been shown to be TBT-resistant. Although iChip has been used in the search for molecules of biomedical interest here we demonstrate its promising application in bioremediation.

Indexed as

Trialkyltin CompoundsWater Pollutants, ChemicalBacteriaBiodegradation, EnvironmentalTrialkyltin CompoundstributyltinWater Pollutants, ChemicalBacterial isolationBioremediationHigh throughput isolationIsolation chipTributyltin

Identifiers

PMID35948836
PMCPMC9365728
OpenAlexW4291002567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.